Full Press Release Details
Media
• November 26, 2024
IRWD Positive Sentiment
Ironwood Pharmaceuticals to Participate in the Piper Sandler 36th Annual Healthcare Conference
Key Takeaway: Ironwood Pharmaceuticals is set to participate in the Piper Sandler 36th Annual Healthcare Conference. This engagement highlights the company's commitment to sharing its advancements and fostering connections within the healthcare community. The conference serves as a significant opportunity for Ironwood to present its initiatives to potential investors and stakeholders.
Price reaction · baseline $3.35 (2024-11-25 close) · hit after-hours · clean, no other IRWD news in the window
day 0 close
+5.1%
day 1 · peak
+9.6%
day 3
+8.1%
Market Sentiment Analysis
POSITIVE FACTORS
- Ironwood Pharmaceuticals is actively participating in a prominent healthcare conference.
- The event provides a platform for showcasing their developments.
- Engagement in such conferences can enhance investor relations.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+57%
120-day peak, hindsight
Typical move
3.8%
average across 2 past catalysts
Lead asset
IW-3718
Phase 3 · Gastroesophageal Reflux Disease (GERD)
Frequently Asked Questions
What conference will Ironwood Pharmaceuticals attend?
Ironwood Pharmaceuticals will attend the Piper Sandler 36th Annual Healthcare Conference.
When is the Piper Sandler Healthcare Conference?
The conference is scheduled for November 26, 2024.
Why is Ironwood participating in the conference?
Ironwood aims to showcase its advancements and engage with investors.